[Advanced testicular seminoma: treatment of residual masses after chemotherapy. A review of 3 cases].
Based on 3 cases of advanced testicular seminoma classified as stage IIC, the treatment of residual masses after chemotherapy is discussed. The excellent therapeutic response confirmed by histological study of the residual masses, which show a fibrotic or necrotic appearance, allows the adoption of a strategy using imaging techniques: either there is persistence of a gland mass syndrome and resection needs to be carried our or retroperitoneal fibrosis is visualised and careful follow up would appear to be sufficient.
Bassoulet
J
J
Service de Radiothérapie Oncologique, Hôpital d'Instruction des Armées du Val-de-Grâce, Paris.
Guillemot
M
M
Merrer
J
J
Pabot du Chatelard
P
P
Beauvais
H
H
Timbal
Y
Y
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004407:Dysgerminoma / Q000145:classification / Q000000981:diagnostic imaging / Q000188:drug therapy*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D013736:Testicular Neoplasms / Q000145:classification / Q000000981:diagnostic imaging / Q000188:drug therapy*; D014057:Tomography, X-Ray Computed
Séminomes testiculaires évolués: traitement des masses résiduelles après chimiothérapie. Réflexions à partir de 3 observations.